VEGFA and cancer: An antibody–analyte–aptamer sandwich assay was also described by Zhu et al. [31] for the detection of vascular endothelial growth factor (VEGF), a regulator of the formation of new blood vessels from existing ones (angiogenesis); VEGF is a biomarker of several diseases such as cancer.